Cargando…

Trajectory patterns of metabolic syndrome severity score and risk of type 2 diabetes

BACKGROUND: The available evidence indicates that the severity of metabolic syndrome tends to worsen progressively over time. We assessed the trajectory of age and sex-specific continuous MetS severity score (cMetS-S) and its association with the development of diabetes during an 18-year follow-up....

Descripción completa

Detalles Bibliográficos
Autores principales:	Amouzegar, Atieh, Honarvar, Mohammadjavad, Masoumi, Safdar, Khalili, Davood, Azizi, Fereidoun, Mehran, Ladan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598905/ https://www.ncbi.nlm.nih.gov/pubmed/37880756 http://dx.doi.org/10.1186/s12967-023-04639-w

Ejemplares similares

Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
por: Honarvar, Mohammadjavad, et al.
Publicado: (2023)

Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
por: Honarvar, Mohammadjavad, et al.
Publicado: (2023)

BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS)
por: Mehran, Ladan, et al.
Publicado: (2022)

Worldwide Recall Rate in Newborn Screening Programs for Congenital Hypothyroidism
por: Mehran, Ladan, et al.
Publicado: (2017)

The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: a meta-analysis
por: Amirabadizadeh, Alireza, et al.
Publicado: (2023)

LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?
por: Azizi, Fereidoun, et al.
Publicado: (2020)

Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained- release liothyronine; a randomized controlled clinical trial
por: Mehran, Ladan, et al.
Publicado: (2023)

Primordial and Primary Preventions of Thyroid Disease
por: Azizi, Fereidoun, et al.
Publicado: (2017)

Tehran Thyroid Study (TTS)
por: Amouzegar, Atieh, et al.
Publicado: (2018)

Management of Hyperthyroidism in Pregnancy: Comparison of Recommendations of American Thyroid Association and Endocrine Society
por: Alamdari, Shahram, et al.
Publicado: (2013)

The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
por: Amouzegar, Atieh, et al.
Publicado: (2017)

Smoking status and changes in thyroid-stimulating hormone and free thyroxine levels during a decade of follow-up: The Tehran thyroid study
por: Kadkhodazadeh, Hoda, et al.
Publicado: (2020)

Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study
por: Mahdavi, Mahdi, et al.
Publicado: (2021)

Assessment of the simultaneous effect of hypothyroidism and thyroid autoimmunity with gestational diabetes on the incidence of type 2 diabetes
por: Zahedi, Maryam, et al.
Publicado: (2020)

Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter
por: Azizi, Fereidoun, et al.
Publicado: (2022)

Trimester-Specific Reference Ranges for Thyroid Hormones in Iranian Pregnant Women
por: Mehran, Ladan, et al.
Publicado: (2013)

Iranian Endocrine Society Guidelines for Screening, Diagnosis, and Management of Gestational Diabetes Mellitus
por: Valizadeh, Majid, et al.
Publicado: (2020)

Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review
por: Abdi, Hengameh, et al.
Publicado: (2018)

Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners
por: Azizi, Fereidoun, et al.
Publicado: (2015)

"Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome?"
por: Hadaegh, Farzad, et al.
Publicado: (2011)

Antithyroid Drugs
por: Abdi, Hengameh, et al.
Publicado: (2019)

Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
por: Azizi, Fereidoun, et al.
Publicado: (2021)

Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
por: Azizi, Fereidoun, et al.
Publicado: (2021)

Prevalence of Subclinical Hypothyroidism in Chronic Kidney Disease in a Population-based Study: Tehran Thyroid Study
por: Kazempour-Ardebili, Sara, et al.
Publicado: (2021)

Leisure-Time Physical Activity and Its Association With Metabolic Risk Factors in Iranian Adults: Tehran Lipid and Glucose Study, 2005–2008
por: Faam, Bita, et al.
Publicado: (2013)

The Impact of Iodine Status on the Recall Rate of the Screening Program for Congenital Hypothyroidism: Findings from Two National Studies in Iran
por: Mehran, Ladan, et al.
Publicado: (2017)

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2019)

Effects of Cinnamon Consumption on Glycemic Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients
por: Talaei, Behrouz, et al.
Publicado: (2017)

Association between Physical Activity and Metabolic Risk Factors in Adolescents: Tehran Lipid and Glucose Study
por: Fam, Bita, et al.
Publicado: (2013)

Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
por: Abdi, Hengameh, et al.
Publicado: (2018)

Patterns of change in obesity indices and other cardiometabolic risk factors before the diagnosis of type 2 diabetes: two decades follow-up of the Tehran lipid and glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2022)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Parizadeh, Donna, et al.
Publicado: (2018)

External validation of the American prediction model for incident type 2 diabetes in the Iranian population
por: Asgari, Samaneh, et al.
Publicado: (2023)

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2021)

Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study
por: Ahi, Salma, et al.
Publicado: (2019)

Correction: Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study
por: Ahi, Salma, et al.
Publicado: (2019)

Systemic Thyroid Hormone Status in Treated Graves’ Disease
por: Azizi, Fereidoun, et al.
Publicado: (2019)

Association Between Serum Nitric Oxide Level and Changes in Thyroid Function Test in a Population-based Study: Tehran Thyroid Study Participants (TTS)
por: Ghazisaeidi, Behnaz, et al.
Publicado: (2021)

External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population
por: Asgari, Samaneh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jcqkt66lopdou799bvt7rtqrtc